> >Register Now <<

Join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series: "Recent Advances in Neurotherapeutics for Child and Adolescent
Mood Disorders"

Speaker: Paul E. Croarkin, DO, MS

Join Dr. Croarkin for an update on the clinical implementation and research of transcranial magnetic stimulation for adolescents with depression. Dr. Croarkin will also review recent, ongoing, and planned research focused on neurotherapeutics.

At the end of the presentation, attendees will:

• Demonstrate a working knowledge of noninvasive brain stimulation modalities such as transcranial electrical stimulation, transcranial magnetic stimulation, and electroconvulsive therapy.
• Demonstrate the ability to discuss recent studies adapting transcranial magnetic stimulation for adolescents with major depressive disorder.
• Demonstrate the ability to discuss recent research with ketamine in adolescents and to discuss potential future studies and related challenges with psychedelic therapeutic.

Take advantage of our live Q&A session at the conclusion of the webinar.

*Registered attendees will receive access to the on-demand video recording by Friday, Friday, February 7, 2025. You will receive an email notification with instructions on accessing the video. You may register for the on-demand webinar any time after the live webinar.

One hour CME credit is available - Click here for CE Language

When:

USA - February 4, 2025 at 8:00pm EST | 5:00pm PST

UK- February 5, 2025 at 1:00am
GMT

Australia- February 5, 2025 at
12:00pm AEDT

Cost:

Member: $25
Trainee Member: FREE
Non-Member: $50

All Grand Rounds are recorded and available On-Demand. Recordings are available by the Friday after the live event.

> >Register Now <<

About the Speaker: Paul Croarkin, DO, MS

Dr. Croarkin is the Ervin A. and Margaret C. Mueller Director of the Children’s Research Center at Mayo Clinic and the Chair for Pediatric
Research in the Department of Pediatrics and Adolescent Medicine. He is a professor of Psychiatry, Pediatrics, and Pharmacology in the Mayo Clinic College of Medicine and Science. He serves as the Editor-in-Chief for the Journal of Child and Adolescent Psychopharmacloogy.

Dr. Croarkin completed medical school at the University of North Texas Health Science Center. He then completed residency training in psychiatry at Naval Medical Center San Diego, where he served as chief resident. Following this, Dr. Croarkin served as a US Navy psychiatrist in an academic role at Walter Reed Army Medical Center and in an operational setting as a psychiatrist embedded with the 24th Marine Expeditionary Unit in North Babil during Operation Iraqi Freedom. He returned for clinical and research training in child
and adolescent psychiatry at UT Southwestern Medical Center in Dallas, again serving as chief resident. He earned a Master of Science degree with distinction in clinical science from the Graduate School of Biomedical Sciences at UT Southwestern Medical Center. Thereafter, he joined the Mayo Clinic Department of Psychiatry and Psychology.

An expert in child, adolescent, and adult mood disorders, neurotherapeutics, and psychopharmacology, Dr. Croarkin conducts research to develop innovative diagnostic and treatment approaches for children and adolescents. His research has been funded by the National Alliance for Research on Schizophrenia and Depression, the National Institutes of Health, and industry partnerships. His team focuses on adapting and innovating neurotherapeutics for youth with psychiatric disorders while studying GABAergic and glutamatergic
neurotransmission. These efforts have informed and supported the clinical implementation of transcranial magnetic stimulation interventions for adolescents with depression. His findings have been published in numerous peer-reviewed journals, including The Journal of the American Academy Child and Adolescent Psychiatry, JAMA Psychiatry, and Neuropsychopharmacology.

> >Register Now <<